Liraglutide is the active ingredient in two well-known brand-name GLP-1 injections: Victoza, prescribed for type 2 diabetes (typically at doses of 1.2 mg to 1.8 mg per day), and Saxenda, used for weight loss (at a higher daily dose of 3 mg)
GLP-related research Semaglutide, tirzepatide, retatrutide, and related research products
If the medication is covered by your plan, prior authorization is typically required
AIM is present in an IgM-bound form in serum, preventing it from renal excretion, which maintains high AIM levels in blood 14,17,18,19
Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B
The goal is letting your body adjust to the medication, minimizing gastrointestinal side effects , and establishing tolerance